What regulatory approvals are required in Pakistan and the UAE, and what is the timeline for obtaining them?
Regulatory clearâances needed
Pakistan: The transaction must be cleared by the Securities and Exchange Commission of Pakistan (SECP) and the Pakistan Stock Exchange (PSX) (if the shareâissuance will affect the freeâfloat of NWTIâs listed ADRs). A foreignâdirectâinvestment approval from the Ministry of Finance/Board of Investment (BOI) is also required because the deal involves an asset contribution and a new manufacturing venture in the country.
United Arab Emirates: The partnership will be anchored by an UAEâbased headquarters, so it needs approval from the UAE Securities and Commodities Authority (SCA) and the relevant freeâzone regulator (e.g., the Dubai International Financial Centre (DIFC) â DFSA or ADGM if the entity is set up there). A commercialâlicense from the UAE Ministry of Economy is also required to operate the âglobalâsalesâ function from the UAE.
Typical timeline for obtaining the approvals
Jurisdiction | Approvals | Expected timeâframe* |
---|---|---|
Pakistan | SECP & PSX clearance; BOI foreignâinvestment licence | 30â45âŻbusiness days from filing of the SPA and supporting documents |
UAE | SCA/DFSA (or ADGM) licence; Ministry of Economy commercial licence | 45â60âŻbusiness days (the freeâzone regulator usually returns within 4â6âŻweeks, the Ministry of Economy adds another 1â2âŻweeks) |
*These estimates assume the parties submit a complete, compliant package of documents at the outset. Any material revisions or additional information requests can extend the schedule, but historically similar crossâborder jointâventure structures in the region have cleared within the 1â2âŻmonth windows noted above.
Trading implication
Because the approvals are expected to be secured within the next 1â2âŻmonths, the market will likely price in the upside of the partnership on the nearâterm. If the timeline holds, the shareâissuance and asset contribution should be reflected in NWTNâs balance sheet by the end of Q4âŻ2025, providing a catalyst for a shortâtoâmediumâterm bullish move. Traders can consider a buyâonâbreakout if the stock holds above the current resistance (~$12.50) as the approval dates approach, while keeping a stop just below the recent low (~$11.30) to guard against any regulatory delayârelated pullâback.